<?xml version='1.0' encoding='utf-8'?>
<document id="25989889"><sentence text="Modeling approach for multiple transporters-mediated drug-drug interactions in sandwich-cultured human hepatocytes: effect of cyclosporin A on hepatic disposition of mycophenolic acid phenyl-glucuronide."><entity charOffset="126-139" id="DDI-PubMed.25989889.s1.e0" text="cyclosporin A" /><entity charOffset="166-202" id="DDI-PubMed.25989889.s1.e1" text="mycophenolic acid phenyl-glucuronide" /><pair ddi="false" e1="DDI-PubMed.25989889.s1.e0" e2="DDI-PubMed.25989889.s1.e0" /><pair ddi="false" e1="DDI-PubMed.25989889.s1.e0" e2="DDI-PubMed.25989889.s1.e1" /></sentence><sentence text="A lower exposure of mycophenolic acid (MPA) in patients receiving MPA-mofetil in combination with cyclosporin A (CsA) is thought to be due to the inhibition of enterohepatic circulation of phenyl-glucuronide of MPA (MPAG)"><entity charOffset="20-37" id="DDI-PubMed.25989889.s2.e0" text="mycophenolic acid" /><entity charOffset="39-42" id="DDI-PubMed.25989889.s2.e1" text="MPA" /><entity charOffset="66-77" id="DDI-PubMed.25989889.s2.e2" text="MPA-mofetil" /><entity charOffset="98-111" id="DDI-PubMed.25989889.s2.e3" text="cyclosporin A" /><entity charOffset="113-116" id="DDI-PubMed.25989889.s2.e4" text="CsA" /><entity charOffset="189-207" id="DDI-PubMed.25989889.s2.e5" text="phenyl-glucuronide" /><entity charOffset="211-214" id="DDI-PubMed.25989889.s2.e6" text="MPA" /><entity charOffset="216-220" id="DDI-PubMed.25989889.s2.e7" text="MPAG" /><pair ddi="false" e1="DDI-PubMed.25989889.s2.e0" e2="DDI-PubMed.25989889.s2.e0" /><pair ddi="false" e1="DDI-PubMed.25989889.s2.e0" e2="DDI-PubMed.25989889.s2.e1" /><pair ddi="false" e1="DDI-PubMed.25989889.s2.e0" e2="DDI-PubMed.25989889.s2.e2" /><pair ddi="false" e1="DDI-PubMed.25989889.s2.e0" e2="DDI-PubMed.25989889.s2.e3" /><pair ddi="false" e1="DDI-PubMed.25989889.s2.e0" e2="DDI-PubMed.25989889.s2.e4" /><pair ddi="false" e1="DDI-PubMed.25989889.s2.e0" e2="DDI-PubMed.25989889.s2.e5" /><pair ddi="false" e1="DDI-PubMed.25989889.s2.e0" e2="DDI-PubMed.25989889.s2.e6" /><pair ddi="false" e1="DDI-PubMed.25989889.s2.e0" e2="DDI-PubMed.25989889.s2.e7" /><pair ddi="false" e1="DDI-PubMed.25989889.s2.e1" e2="DDI-PubMed.25989889.s2.e1" /><pair ddi="false" e1="DDI-PubMed.25989889.s2.e1" e2="DDI-PubMed.25989889.s2.e2" /><pair ddi="false" e1="DDI-PubMed.25989889.s2.e1" e2="DDI-PubMed.25989889.s2.e3" /><pair ddi="false" e1="DDI-PubMed.25989889.s2.e1" e2="DDI-PubMed.25989889.s2.e4" /><pair ddi="false" e1="DDI-PubMed.25989889.s2.e1" e2="DDI-PubMed.25989889.s2.e5" /><pair ddi="false" e1="DDI-PubMed.25989889.s2.e1" e2="DDI-PubMed.25989889.s2.e6" /><pair ddi="false" e1="DDI-PubMed.25989889.s2.e1" e2="DDI-PubMed.25989889.s2.e7" /><pair ddi="false" e1="DDI-PubMed.25989889.s2.e2" e2="DDI-PubMed.25989889.s2.e2" /><pair ddi="false" e1="DDI-PubMed.25989889.s2.e2" e2="DDI-PubMed.25989889.s2.e3" /><pair ddi="false" e1="DDI-PubMed.25989889.s2.e2" e2="DDI-PubMed.25989889.s2.e4" /><pair ddi="false" e1="DDI-PubMed.25989889.s2.e2" e2="DDI-PubMed.25989889.s2.e5" /><pair ddi="false" e1="DDI-PubMed.25989889.s2.e2" e2="DDI-PubMed.25989889.s2.e6" /><pair ddi="false" e1="DDI-PubMed.25989889.s2.e2" e2="DDI-PubMed.25989889.s2.e7" /><pair ddi="false" e1="DDI-PubMed.25989889.s2.e3" e2="DDI-PubMed.25989889.s2.e3" /><pair ddi="false" e1="DDI-PubMed.25989889.s2.e3" e2="DDI-PubMed.25989889.s2.e4" /><pair ddi="false" e1="DDI-PubMed.25989889.s2.e3" e2="DDI-PubMed.25989889.s2.e5" /><pair ddi="false" e1="DDI-PubMed.25989889.s2.e3" e2="DDI-PubMed.25989889.s2.e6" /><pair ddi="false" e1="DDI-PubMed.25989889.s2.e3" e2="DDI-PubMed.25989889.s2.e7" /><pair ddi="false" e1="DDI-PubMed.25989889.s2.e4" e2="DDI-PubMed.25989889.s2.e4" /><pair ddi="false" e1="DDI-PubMed.25989889.s2.e4" e2="DDI-PubMed.25989889.s2.e5" /><pair ddi="false" e1="DDI-PubMed.25989889.s2.e4" e2="DDI-PubMed.25989889.s2.e6" /><pair ddi="false" e1="DDI-PubMed.25989889.s2.e4" e2="DDI-PubMed.25989889.s2.e7" /><pair ddi="false" e1="DDI-PubMed.25989889.s2.e5" e2="DDI-PubMed.25989889.s2.e5" /><pair ddi="false" e1="DDI-PubMed.25989889.s2.e5" e2="DDI-PubMed.25989889.s2.e6" /><pair ddi="false" e1="DDI-PubMed.25989889.s2.e5" e2="DDI-PubMed.25989889.s2.e7" /><pair ddi="false" e1="DDI-PubMed.25989889.s2.e6" e2="DDI-PubMed.25989889.s2.e6" /><pair ddi="false" e1="DDI-PubMed.25989889.s2.e6" e2="DDI-PubMed.25989889.s2.e7" /></sentence><sentence text=" This study aimed to evaluate the interaction of CsA with hepatic disposition of MPA and MPAG in sandwich-cultured human hepatocytes (SCHH) by a mathematical modeling approach"><entity charOffset="81-84" id="DDI-PubMed.25989889.s3.e0" text="MPA" /><entity charOffset="89-92" id="DDI-PubMed.25989889.s3.e1" text="MPA" /><entity charOffset="49-52" id="DDI-PubMed.25989889.s3.e2" text="CsA" /><pair ddi="false" e1="DDI-PubMed.25989889.s3.e2" e2="DDI-PubMed.25989889.s3.e2" /><pair ddi="false" e1="DDI-PubMed.25989889.s3.e2" e2="DDI-PubMed.25989889.s3.e0" /><pair ddi="false" e1="DDI-PubMed.25989889.s3.e2" e2="DDI-PubMed.25989889.s3.e1" /><pair ddi="false" e1="DDI-PubMed.25989889.s3.e0" e2="DDI-PubMed.25989889.s3.e0" /><pair ddi="false" e1="DDI-PubMed.25989889.s3.e0" e2="DDI-PubMed.25989889.s3.e1" /></sentence><sentence text=" In addition, the inhibition of CsA for glucuronidation of MPA to MPAG was examined in human liver microsomes"><entity charOffset="59-61" id="DDI-PubMed.25989889.s4.e0" text="MPA" /><entity charOffset="66-68" id="DDI-PubMed.25989889.s4.e1" text="MPA" /><entity charOffset="32-34" id="DDI-PubMed.25989889.s4.e2" text="CsA" /><pair ddi="false" e1="DDI-PubMed.25989889.s4.e2" e2="DDI-PubMed.25989889.s4.e2" /><pair ddi="false" e1="DDI-PubMed.25989889.s4.e2" e2="DDI-PubMed.25989889.s4.e0" /><pair ddi="false" e1="DDI-PubMed.25989889.s4.e2" e2="DDI-PubMed.25989889.s4.e1" /><pair ddi="false" e1="DDI-PubMed.25989889.s4.e0" e2="DDI-PubMed.25989889.s4.e0" /><pair ddi="false" e1="DDI-PubMed.25989889.s4.e0" e2="DDI-PubMed.25989889.s4.e1" /></sentence><sentence text=" Inhibitory parameters of CsA for hepatic disposition of MPAG were estimated using a non-linear mixed effect model program, NONMEM"><entity charOffset="57-59" id="DDI-PubMed.25989889.s5.e0" text="MPA" /><entity charOffset="26-28" id="DDI-PubMed.25989889.s5.e1" text="CsA" /><pair ddi="false" e1="DDI-PubMed.25989889.s5.e1" e2="DDI-PubMed.25989889.s5.e1" /><pair ddi="false" e1="DDI-PubMed.25989889.s5.e1" e2="DDI-PubMed.25989889.s5.e0" /></sentence><sentence text=" As a result, CsA did not influence the conversion of MPA to MPAG in either SCHH or human liver microsomes"><entity charOffset="76-80" id="DDI-PubMed.25989889.s6.e0" text="SCHH" /><entity charOffset="54-57" id="DDI-PubMed.25989889.s6.e1" text="MPA" /><entity charOffset="61-64" id="DDI-PubMed.25989889.s6.e2" text="MPA" /><entity charOffset="14-17" id="DDI-PubMed.25989889.s6.e3" text="CsA" /><pair ddi="false" e1="DDI-PubMed.25989889.s6.e3" e2="DDI-PubMed.25989889.s6.e3" /><pair ddi="false" e1="DDI-PubMed.25989889.s6.e3" e2="DDI-PubMed.25989889.s6.e1" /><pair ddi="false" e1="DDI-PubMed.25989889.s6.e3" e2="DDI-PubMed.25989889.s6.e2" /><pair ddi="false" e1="DDI-PubMed.25989889.s6.e3" e2="DDI-PubMed.25989889.s6.e0" /><pair ddi="false" e1="DDI-PubMed.25989889.s6.e1" e2="DDI-PubMed.25989889.s6.e1" /><pair ddi="false" e1="DDI-PubMed.25989889.s6.e1" e2="DDI-PubMed.25989889.s6.e2" /><pair ddi="false" e1="DDI-PubMed.25989889.s6.e1" e2="DDI-PubMed.25989889.s6.e0" /><pair ddi="false" e1="DDI-PubMed.25989889.s6.e2" e2="DDI-PubMed.25989889.s6.e2" /><pair ddi="false" e1="DDI-PubMed.25989889.s6.e2" e2="DDI-PubMed.25989889.s6.e0" /></sentence><sentence text=" In contrast, CsA inhibited the basolateral uptake of MPAG with an estimated maximum inhibitory effect (Imax) of 32"><entity charOffset="54-56" id="DDI-PubMed.25989889.s7.e0" text="MPA" /><entity charOffset="14-16" id="DDI-PubMed.25989889.s7.e1" text="CsA" /><pair ddi="false" e1="DDI-PubMed.25989889.s7.e1" e2="DDI-PubMed.25989889.s7.e1" /><pair ddi="false" e1="DDI-PubMed.25989889.s7.e1" e2="DDI-PubMed.25989889.s7.e0" /></sentence><sentence text="4%" /><sentence text=" CsA also inhibited basolateral efflux and biliary excretion of MPAG formed in SCHH, and the concentration producing 50% of Imax (IC50) for biliary excretion was lower than that for basolateral efflux"><entity charOffset="64-66" id="DDI-PubMed.25989889.s9.e0" text="MPA" /><entity charOffset="1-3" id="DDI-PubMed.25989889.s9.e1" text="CsA" /><entity charOffset="79-81" id="DDI-PubMed.25989889.s9.e2" text="SCHH" /><pair ddi="false" e1="DDI-PubMed.25989889.s9.e1" e2="DDI-PubMed.25989889.s9.e1" /><pair ddi="false" e1="DDI-PubMed.25989889.s9.e1" e2="DDI-PubMed.25989889.s9.e0" /><pair ddi="false" e1="DDI-PubMed.25989889.s9.e1" e2="DDI-PubMed.25989889.s9.e2" /><pair ddi="false" e1="DDI-PubMed.25989889.s9.e0" e2="DDI-PubMed.25989889.s9.e0" /><pair ddi="false" e1="DDI-PubMed.25989889.s9.e0" e2="DDI-PubMed.25989889.s9.e2" /></sentence><sentence text=" Our modeling approach suggests that CsA inhibits both basolateral uptake and biliary excretion of MPAG and leads to changes in systemic exposure of MPA and MPAG in humans"><entity charOffset="99-102" id="DDI-PubMed.25989889.s10.e0" text="MPA" /><entity charOffset="149-152" id="DDI-PubMed.25989889.s10.e1" text="MPA" /><entity charOffset="157-160" id="DDI-PubMed.25989889.s10.e2" text="MPA" /><entity charOffset="37-40" id="DDI-PubMed.25989889.s10.e3" text="CsA" /><pair ddi="false" e1="DDI-PubMed.25989889.s10.e3" e2="DDI-PubMed.25989889.s10.e3" /><pair ddi="false" e1="DDI-PubMed.25989889.s10.e3" e2="DDI-PubMed.25989889.s10.e0" /><pair ddi="false" e1="DDI-PubMed.25989889.s10.e3" e2="DDI-PubMed.25989889.s10.e1" /><pair ddi="false" e1="DDI-PubMed.25989889.s10.e3" e2="DDI-PubMed.25989889.s10.e2" /><pair ddi="false" e1="DDI-PubMed.25989889.s10.e0" e2="DDI-PubMed.25989889.s10.e0" /><pair ddi="false" e1="DDI-PubMed.25989889.s10.e0" e2="DDI-PubMed.25989889.s10.e1" /><pair ddi="false" e1="DDI-PubMed.25989889.s10.e0" e2="DDI-PubMed.25989889.s10.e2" /><pair ddi="false" e1="DDI-PubMed.25989889.s10.e1" e2="DDI-PubMed.25989889.s10.e1" /><pair ddi="false" e1="DDI-PubMed.25989889.s10.e1" e2="DDI-PubMed.25989889.s10.e2" /></sentence><sentence text="" /></document>